You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKesson
Medtronic
McKinsey
Mallinckrodt
AstraZeneca

Last Updated: May 12, 2021

DrugPatentWatch Database Preview

Litigation Details for ACADIA Pharmaceuticals Inc. v. Aurobindo Pharma Limited (D. Del. 2020)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

ACADIA Pharmaceuticals Inc. v. Aurobindo Pharma Limited (D. Del. 2020)

Docket   Get Started for $10 Date Filed 2020-07-24
Court District Court, D. Delaware Date Terminated
Cause 35:271 Patent Infringement Assigned To Richard Gibson Andrews
Jury Demand None Referred To
Parties AUROBINDO PHARMA USA, INC.
Patents 10,028,944; 10,449,185; 7,601,740; 7,659,285; 7,732,615; 7,923,564; 8,618,130; 8,921,393; 9,566,271
Attorneys Jessica Marie Jones
Firms Morris James LLP
Link to Docket External link to docket
Small Molecule Drugs cited in ACADIA Pharmaceuticals Inc. v. Aurobindo Pharma Limited
The small molecule drug covered by the patents cited in this case is   Get Started for $10 .

Details for ACADIA Pharmaceuticals Inc. v. Aurobindo Pharma Limited (D. Del. 2020)

Date Filed Document No. Description Snippet Link To Document
2020-07-24 1 Complaint States Patent Nos. 7,601,740 (“the ’740 patent”), 7,732,615 (“the ’615 patent”), 10,449,185 (“the ’185…’185 patent”), and 10,646,480 (“the ’480 patent”) (collectively “the patents-in-suit”). This action arises… of the ’740 patent is attached as Exhibit A. 26. ACADIA owns the ’740 patent. 27.…of the ’615 patent is attached as Exhibit B. 28. ACADIA owns the ’615 patent. 29.… of the ’185 patent is attached as Exhibit C. 30. ACADIA owns the ’185 patent. External link to document
2020-09-01 12 Patent/Trademark Report to Commissioner of Patents ,923,564 ;8,618,130 ;8,921,393 ;9,566,271 ;10,028,944 . (Dorsney, Kenneth) (Entered: 09/01/2020) 1… Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,659,285 ;7,923,564… 24 July 2020 1:20-cv-00985 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2020-07-24 4 Patent/Trademark Report to Commissioner of Patents Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,601,740 ;7,732,615 ;10,449,185 ;10,646,480… 24 July 2020 1:20-cv-00985 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Boehringer Ingelheim
Merck
Moodys
AstraZeneca
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.